Literature DB >> 17156369

Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes.

Gaelle Champeil-Potokar1, Catherine Chaumontet, Philippe Guesnet, Monique Lavialle, Isabelle Denis.   

Abstract

Although it is agreed that n-3 polyunsaturated fatty acids (PUFAs) are important for brain function, it has yet to be demonstrated how they are involved in precise cellular mechanisms. We investigated the role of enhanced n-3 PUFA in astrocyte membranes on the gap junction capacity of these cells. Astrocytes isolated from newborn rat cortices were grown in medium supplemented with docosahexaenoic acid (DHA), the main n-3 PUFA in cell membranes, or arachidonic acid (AA), the main n-6 PUFA, plus an antioxidant (alpha-tocopherol or N-acetyl-cystein) to prevent peroxidation. The resulting three populations of astrocytes differed markedly in their n-3:n-6 PUFA ratios in phosphatidylethanolamine and phosphatidylcholine, the main phospholipids in membranes. DHA-supplemented cells had a physiological high n-3:n-6 ratio (1.58), unsupplemented cells had a low n-3:n-6 ratio (0.66) and AA-supplemented cells had a very low n-3:n-6 ratio (0.36), with excess n-6 PUFA. DHA-supplemented astrocytes had a greater gap junction capacity than unsupplemented cells or AA-supplemented cells. The enhanced gap junction coupling of DHA-enriched cells was associated with a more functional distribution of connexin 43 at cell interfaces (shown by immunocytochemistry) and more of the main phosphorylated isoform of connexin 43. These findings suggest that the high n-3:n-6 PUFA ratio that occurs naturally in astrocyte membranes is needed for optimal gap junction coupling in these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17156369     DOI: 10.1111/j.1460-9568.2006.05185.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  19 in total

1.  DHA inhibits ER Ca2+ release and ER stress in astrocytes following in vitro ischemia.

Authors:  Gulnaz Begum; Douglas Kintner; Yan Liu; Samuel W Cramer; Dandan Sun
Journal:  J Neurochem       Date:  2012-02       Impact factor: 5.372

2.  PUFAs supplementation affects the renal expression of pannexin 1 and connexins in diabetic kidney of rats.

Authors:  Martina Luetić; Marija Vitlov Uljević; Tomislav Mašek; Benjamin Benzon; Katarina Vukojević; Natalija Filipović
Journal:  Histochem Cell Biol       Date:  2019-12-20       Impact factor: 4.304

3.  Docosahexaenoic Acid (DHA) Induced Morphological Differentiation of Astrocytes Is Associated with Transcriptional Upregulation and Endocytosis of β2-AR.

Authors:  Moitreyi Das; Sumantra Das
Journal:  Mol Neurobiol       Date:  2018-07-27       Impact factor: 5.590

4.  Glutamate homeostasis in the adult rat prefrontal cortex is altered by cortical docosahexaenoic acid accrual during adolescence: An in vivo1H MRS study.

Authors:  Robert K McNamara; Ruth H Asch; Jennifer D Schurdak; Diana M Lindquist
Journal:  Psychiatry Res Neuroimaging       Date:  2017-10-11       Impact factor: 2.376

5.  Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats.

Authors:  Jana Radosinska; Barbara Bacova; Iveta Bernatova; Jana Navarova; Anna Zhukovska; Angela Shysh; Ludmila Okruhlicova; Narcis Tribulova
Journal:  Mol Cell Biochem       Date:  2010-10-21       Impact factor: 3.396

6.  Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study.

Authors:  Robert K McNamara; Jessica Able; Ronald Jandacek; Therese Rider; Patrick Tso; James C Eliassen; David Alfieri; Wade Weber; Kelly Jarvis; Melissa P DelBello; Stephen M Strakowski; Caleb M Adler
Journal:  Am J Clin Nutr       Date:  2010-02-03       Impact factor: 7.045

Review 7.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

8.  Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study.

Authors:  Stacey Ageranioti Bélanger; Michel Vanasse; Schohraya Spahis; Marie-Pierre Sylvestre; Sarah Lippé; François L'heureux; Parviz Ghadirian; Catherine-Marie Vanasse; Emile Levy
Journal:  Paediatr Child Health       Date:  2009-02       Impact factor: 2.253

9.  The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders.

Authors:  Raymond H Thomas; Melissa M Meeking; Jennifer R Mepham; Lisa Tichenoff; Fred Possmayer; Suya Liu; Derrick F MacFabe
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

10.  Fatty acid patterns early after premature birth, simultaneously analysed in mothers' food, breast milk and serum phospholipids of mothers and infants.

Authors:  Karl-Göran Sabel; Cristina Lundqvist-Persson; Elsa Bona; Max Petzold; Birgitta Strandvik
Journal:  Lipids Health Dis       Date:  2009-06-10       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.